Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Clover

Missed the Hims & Hers Rally? Clover Health Could Be Next

After a steep decline from its all-time high prices, shares of Hims & Hers are now recovering to show investor interest in the space.

MarketBeat

“People think we’re a pop band. But we never have been. We just had some huge success that hurt us a little”: how Huey Lewis & The News became America’s favourite good time rock’n’roll band

Huey Lewis & The News were the ultimate bar-room rockers made good – all it took was a little nudge from Mutt Lange and Michael J Fox

Louder

4-H teams with Netflix's 'Spy Kids: Armageddon' to launch new learning platform Clover

The National 4-H Council is growing in a new direction – online – by launching its e-learning platform Clover with a collaboration with Netflix and its new movie “Spy Kids: Armageddon.”

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Clover Health Investments (CLOV): Buy, Hold or Sell End of June?

Clover Health (CLOV) has been subject to several lawsuits and federal investigations. Also, the company’s bottom line is in the red. However, CLOV is ramping up its efforts to accelerate its path to profitability. So, should you Buy, Hold or Sell the stock now? Read on to learn my views.

StockNews.com

Shift4 Growth Rides International Expansion, Next-Gen Payment System

Shift4 Payments is the IBD Stock of the Day as the digital payment processor rides a relative strength line near 52-week highs amid stock market volatility and the banking crisis.

Investors Business Daily

Stock Of The Day Shift4 Faces Risk, But Also A Possible Musk Upside

Shift4 Payments is the IBD Stock of the Day as shares in the digital payment processor consolidate heading into 2023 and investors mull risks.

Investors Business Daily

Shift4 Sinks On Third-Quarter Earnings As It Hosts Investor Day

Shift4 Payments reported earnings and revenue that topped estimates while the company raised its full-year outlook. But shares fell.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

The Clover Group buys Belfast bar the Eglantine Inn creating 30 new jobs and planning £500k refurbishment

The venue was first designed in 1988 by the same architects as the iconic Crown Bar

Belfast Live

Noted New Orleans social services group drops racist's name

A New Orleans social services nonprofit long known as the Kingsley House has ditched the name of a Victorian clergyman found to have held profoundly racist views

The Independent UK

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

Pfizer (NYSE:PFE) announced positive top-line data from the Phase 3 clinical trial RENOIR investigating its bivalent RSV prefusion F vaccine candidate, RSVpreF, when administered to adults 60 years of age or older. Pfizer, Inc. shares traded in a range of $47.27 to $47.95 on day volume of 14.45 million shares, closed…

Benzinga

Clover Wants You To Stay Breezy With The Netstyle 2 Jacket

Italian gear and apparel maker Clover introduces the Netstyle 2 riding jacket for the 2022 season. This mesh jacket is meant to keep you cool this summer.

RideApart

China's Clover says its Covid booster shot candidate lifts antibody against Omicron

BEIJING: China's Clover Biopharmaceuticals said on Monday a booster shot of its Covid-19 vaccine candidate significantly increased antibody response against the Omicron coronavirus variant from levels seen after two primary shots.

Bangkok Post

Victoria's Secret to pay B285m settlement to laid-off Thai workers

Thai workers who were sacked last year from a factory supplying global lingerie brands including Victoria's Secret will receive 285.2 million baht, in what labour activists say is the biggest settlement of its kind in the global garment industry.

Bangkok Post

How Clover Mortgage Is Helping Metro Detroiters Save On Homeownership As Rates Begin To Climb

Through the pandemic, Americans went on a homebuying spree. Amidst trends accelerated by work-from-home and pandemic isolation, families, some of which were first-time home buyers, drew on an already limited supply.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Dynavax's Adjuvant-Based Bivalent COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action

Clover Biopharmaceuticals Ltd announced new promising data from a preclinical study on its bivalent vaccine candidate, which combines the trimeric spike antigens from the original SARS-CoV-2 strain and the omicron variant. Clover developed the SCB-2019 antigen, a stabilized trimeric form of the S-protein based on the original strain of the SARS-CoV-2 virus. It…

Benzinga

Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron

Clover Biopharmaceuticals Ltd's follow-up analysis for efficacy in the SPECTRA Phase 2/3 trial of SCB-2019 COVID-19 vaccine provided high and durable protection in individuals five months after the second dose. The follow-up analysis involved 26,400 individuals. Against any variant, efficacy was maintained at 100% against severe COVID-19 and 95% against COVID-19 associated…

Benzinga

Why Did Chelsea Clinton Buy Shares Of This Healthcare Company?

Clover Health Investments Corp (NASDAQ: CLOV) shares are surging Monday following insider buying from a prominent public figure.

StockNews.com

Clover Health vs. Anthem: Which Healthcare Plan Stock is a Better Buy?

An aging population and rising healthcare spending have been driving the growth of the healthcare plans industry. Therefore, both Anthem (ANTM) and Clover (CLOV) should see an increase in demand for their products. But which one of these stocks is a better buy right now? Read on.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Better Buy for 2022: Humana vs. Clover Health

The rising aging population and the increasing spending on healthcare have been driving the health insurance industry’s growth. So, Humana (HUM) and Clover (CLOV) should benefit. But which of these two stocks is a better buy now? Read more to find out.

Geekflare

16 Best Payment Processing Companies and Solutions

Explore the best payment processing services that offer secure, fast, and flexible transaction processing to enhance your business efficiency and customer experience.

TechRadar

Clover point of sale (POS) review

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.